High in vitro antimicrobial activity of synthetic antimicrobial peptidomimetics against staphylococcal biofilms

Journal of Antimicrobial Chemotherapy

Volumn 63, Issue 1, 2009, Pages 136-145

  Flemming, Kristina ^a   Klingenberg, Claus ^a,b   Cavanagh, Jorun Pauline ^b   Sletteng, Merethe ^a,b   Stensen, Wenche ^b,c   Svendsen, John Sigurd ^b,c   Flægstad, Trond ^a,b  

^a UNIVERSITY HOSPITAL OF NORTH NORWAY   (Norway)

^b UNIVERSITY OF TROMSØ   (Norway)

^c LYTIX BIOPHARMA AS   (Norway)

Author keywords

Alamar blue; Biofilm inhibitory concentrations; Staphylococci

Indexed keywords

ANTIBIOTIC AGENT; GENTAMICIN; KP 14; LINEZOLID; LTX 10; LTX 5; LTX 9; OXACILLIN; RIFAMPICIN; TETRACYCLINE; UNCLASSIFIED DRUG; VANCOMYCIN;

ANTIMICROBIAL ACTIVITY; ARTICLE; BACTERIAL METABOLISM; BACTERIUM CULTURE; BIOFILM; CONFOCAL LASER MICROSCOPY; CONTROLLED STUDY; IN VITRO STUDY; MICROTITER PLATE ASSAY; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; OXIDATION REDUCTION REACTION; STAINING; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS EPIDERMIDIS; STAPHYLOCOCCUS HAEMOLYTICUS;

ANTI-BACTERIAL AGENTS; ANTIMICROBIAL CATIONIC PEPTIDES; BIOFILMS; MICROBIAL SENSITIVITY TESTS; MICROBIAL VIABILITY; MICROSCOPY, CONFOCAL; OXAZINES; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS EPIDERMIDIS; STAPHYLOCOCCUS HAEMOLYTICUS; XANTHENES;

EID: 57649234912     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dkn464     Document Type: Article

References (41)

1. Davis SC, Ricotti C, Cazzaniga A et al. Microscopic and physiologic evidence for biofilm-associated wound colonization in vivo. Wound Repair Regen 2008; 16: 23-9.
2. Schulin T, Voss A. Coagulase-negative staphylococci as a cause of infections related to intravascular prosthetic devices: Limitations of present therapy. Clin Microbiol Infect 2001; 7 Suppl 4: 1-7.
3. Dougherty SH. Pathobiology of infection in prosthetic devices. Rev Infect Dis 1988; 10: 1102-17.
4. Otto M. Staphylococcal biofilms. Curr Top Microbiol Immunol 2008; 322: 207-28.
5. Holland LM, O'Donnell ST, Ryjenkov DA et al. A staphylococcal GGDEF domain protein regulates biofilm formation independently of cyclic dimeric GMP. J Bacteriol 2008; 190: 5178-89.
6. Kristian SA, Birkenstock TA, Sauder U et al. Biofilm formation induces C3a release and protects Staphylococcus epidermidis from IgG and complement deposition and from neutrophil-dependent killing. J Infect Dis 2008; 197: 1028-35.
7. Cerca N, Martins S, Cerca F et al. Comparative assessment of antibiotic susceptibility of coagulase-negative staphylococci in biofilm versus planktonic culture as assessed by bacterial enumeration or rapid XTT colorimetry. J Antimicrob Chemother 2005; 56: 331-6.
8. Stewart PS, Costerton JW. Antibiotic resistance of bacteria in biofilms. Lancet 2001; 358: 135-8.
9. Donlan RM. Role of biofilms in antimicrobial resistance. ASAIO J 2000; 46: S47-52.
10. Donlan RM, Costerton JW. Biofilms: Survival mechanisms of clinically relevant microorganisms. Clin Microbiol Rev 2002; 15: 167-93.
11. Peeters E, Nelis HJ, Coenye T. Comparison of multiple methods for quantification of microbial biofilms grown in microtiter plates. J Microbiol Methods 2008; 72: 157-65.
12. Pettit RK, Weber CA, Kean MJ et al. Microplate Alamar Blue assay for Staphylococcus epidermidis biofilm susceptibility testing. Antimicrob Agents Chemother 2005; 49: 2612-7.
13. Tote K, Vanden Berghe D, Maes L et al. A new colorimetric microtitre model for the detection of Staphylococcus aureus biofilms. Lett Appl Microbiol 2008; 46: 249-54.
14. Wei GX, Campagna AN, Bobek LA. Effect of MUC7 peptides on the growth of bacteria and on Streptococcus mutans biofilm. J Antimicrob Chemother 2006; 57: 1100-9.
15. Peeters E, Nelis HJ, Coenye T. Resistance of planktonic and biofilm-grown Burkholderia cepacia complex isolates to the transition metal gallium. J Antimicrob Chemother 2008; 61: 1062-5.
16. Hancock RE, Scott MG. The role of antimicrobial peptides in animal defenses. Proc Natl Acad Sci USA 2000; 97: 8856-61.
17. Raj PA, Dentino AR. Current status of defensins and their role in innate and adaptive immunity. FEMS Microbiol Lett 2002; 206: 9-18.
18. Zasloff M. Antimicrobial peptides of multicellular organisms. Nature 2002; 415: 389-95.
19. Hancock RE, Chapple DS. Peptide antibiotics. Antimicrob Agents Chemother 1999; 43: 1317-23.
20. Wu M, Maier E, Benz R et al. Mechanism of interaction of different classes of cationic antimicrobial peptides with planar bilayers and with the cytoplasmic membrane of Escherichia coli. Biochemistry 1999; 38: 7235-42.
21. McPhee JB, Hancock RE. Function and therapeutic potential of host defence peptides. J Pept Sci 2005; 11: 677-87.
22. Herbert S, Bera A, Nerz C et al. Molecular basis of resistance to muramidase and cationic antimicrobial peptide activity of lysozyme in staphylococci. PLoS Pathog 2007; 3: E102.
23. Jenssen H, Hamill P, Hancock RE. Peptide antimicrobial agents. Clin Microbiol Rev 2006; 19: 491-511.
24. Zasloff M. Antimicrobial peptides of multicellular organisms. Nature 2002; 415: 389-95.
25. Beckloff N, Laube D, Castro T et al. Activity of an antimicrobial peptide mimetic against planktonic and biofilm cultures of oral pathogens. Antimicrob Agents Chemother 2007; 51: 4125-32.
26. Haug BE, Stensen W, Kalaaji M et al. Synthetic antimicrobial peptidomimetics with therapeutic potential. J Med Chem 2008; 51 4306-14.
27. Haug BE, Strom MB, Svendsen JS. The medicinal chemistry of short lactoferricin-based antibacterial peptides. Curr Med Chem 2007; 14: 1-18.
28. Clinical and Laboratory Standards Institute. Performance Standards for Antimicrobial Susceptibility Testing: Fifteenth Informational Supplement M100-S15. CLSI, Wayne, PA, USA, 2005.
29. EUCAST - European Committee on Antimicrobial Testing. Clinical Breakpoints http://www.srga.org/eucastwt/MICTAB/index.html.
30. de Silva GD, Kantzanou M, Justice A et al. The ica operon and biofilm production in coagulase-negative staphylococci associated with carriage and disease in a neonatal intensive care unit. J Clin Microbiol 2002; 40: 382-8.
31. Christensen GD, Simpson WA, Younger JJ et al. Adherence of coagulase-negative staphylococci to plastic tissue culture plates: A quantitative model for the adherence of staphylococci to medical devices. J Clin Microbiol 1985; 22: 996-1006.
32. Kussell E, Kishony R, Balaban NQ et al. Bacterial persistence: A model of survival in changing environments. Genetics 2005; 169 1807-14.
33. Monzon M, Oteiza C, Leiva J et al. Biofilm testing of Staphylococcus epidermidis clinical isolates: Low performance of vancomycin in relation to other antibiotics. Diagn Microbiol Infect Dis 2002; 44: 319-24.
34. Rode TM, Langsrud S, Holck A et al. Different patterns of biofilm formation in Staphylococcus aureus under food-related stress conditions. Int J Food Microbiol 2007; 116: 372-83.
35. Folkesson A, Haagensen JA, Zampaloni C et al. Biofilm induced tolerance towards antimicrobial peptides. PLoS One 2008; 3: e1891.
36. Altman H, Steinberg D, Porat Y et al. In vitro assessment of antimicrobial peptides as potential agents against several oral bacteria. J Antimicrob Chemother 2006; 58: 198-201.
37. Eckert R, He J, Yarbrough DK et al. Targeted killing of Streptococcus mutans by a pheromone-guided 'smart' antimicrobial peptide. Antimicrob Agents Chemother 2006; 50: 3651-7.
38. Knobloch JK, Von Osten H, Horstkotte MA et al. Minimal attachment killing (MAK): A versatile method for susceptibility testing of attached biofilm-positive and -negative Staphylococcus epidermidis. Med Microbiol Immunol (Berl) 2002; 191: 107-14.
39. Labthavikul P, Petersen PJ, Bradford PA. In vitro activity of tigecycline against Staphylococcus epidermidis growing in an adherent-cell biofilm model. Antimicrob Agents Chemother 2003; 47: 3967-9.
40. Harder J, Bartels J, Christophers E et al. A peptide antibiotic from human skin. Nature 1997; 387: 861.
41. Peschel A, Otto M, Jack RW et al. Inactivation of the dlt operon in Staphylococcus aureus confers sensitivity to defensins, protegrins, and other antimicrobial peptides. J Biol Chem 1999; 274: 8405-10.